Cost Versus Labor Model

During this segment of Cell & Gene Live “Building An In-House Cell & Gene Manufacturing Facility – Best Practices & Lessons Learned”, panelists Will Junker, Head of Vector Manufacturing Quality at Kite Pharma and Mitch Lower, SVP of Technical Operations at Kriya Therapeutics explain how companies can balance the cost and labor model, as an empty GMP facility costs a great deal of money.